WallStreetZenWallStreetZen

NASDAQ: CCAP
Crescent Capital Bdc Inc Stock

$13.62+0.15 (+1.11%)
Updated May 26, 2023
CCAP Price
$13.62
Fair Value Price
$13.85
Market Cap
$504.78M
52 Week Low
$12.55
52 Week High
$18.20
P/E
64.86x
P/B
0.7x
P/S
3.41x
PEG
N/A
Dividend Yield
12.78%
Revenue
$129.62M
Earnings
$7.11M
Gross Margin
53.8%
Operating Margin
5.64%
Profit Margin
5.5%
Debt to Equity
1.27
Operating Cash Flow
$33M
Beta
0.66
Next Earnings
N/A
Ex-Dividend
Jun 29, 2023
Next Dividend
Jul 17, 2023

CCAP Overview

Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CCAP scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CCAP ($13.62) is undervalued by 1.67% relative to our estimate of its Fair Value price of $13.85 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CCAP ($13.62) is not significantly undervalued (1.67%) relative to our estimate of its Fair Value price of $13.85 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CCAP was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more CCAP due diligence checks available for Premium users.

Be the first to know about important CCAP news, forecast changes, insider trades & much more!

CCAP News

Valuation

CCAP fair value

Fair Value of CCAP stock based on Discounted Cash Flow (DCF)
Price
$13.62
Fair Value
$13.85
Undervalued by
1.67%
CCAP ($13.62) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CCAP ($13.62) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CCAP was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CCAP price to earnings (PE)

For valuing profitable companies with steady earnings
Company
64.86x
Industry
46.45x
Market
54.23x
CCAP is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CCAP is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

CCAP price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.7x
Industry
1.94x
CCAP is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CCAP's financial health

Profit margin

Revenue
$39.3M
Net Income
$7.8M
Profit Margin
19.8%
CCAP's Earnings (EBIT) of $7.31M... subscribe to Premium to read more.
Interest Coverage Financials
CCAP's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.6B
Liabilities
$912.7M
Debt to equity
1.27
CCAP's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CCAP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$16.0M
Investing
$0.0
Financing
$1.4M
CCAP's operating cash flow ($32.79M)... subscribe to Premium to read more.
Debt Coverage Financials

CCAP vs Asset Management Stocks

TickerMarket Cap1d %P/EP/B
CCAP$504.78M+1.11%64.86x0.70x
DHIL$485.08M+2.06%11.36x2.87x
PFLT$534.62M-0.46%-30.71x0.96x
FDUS$467.53M+0.97%11.62x0.96x
CION$545.27M+0.81%49.75x0.66x

Crescent Capital Bdc Stock FAQ

What is Crescent Capital Bdc's quote symbol?

(NASDAQ: CCAP) Crescent Capital Bdc trades on the NASDAQ under the ticker symbol CCAP. Crescent Capital Bdc stock quotes can also be displayed as NASDAQ: CCAP.

If you're new to stock investing, here's how to buy Crescent Capital Bdc stock.

What is the 52 week high and low for Crescent Capital Bdc (NASDAQ: CCAP)?

(NASDAQ: CCAP) Crescent Capital Bdc's 52-week high was $18.20, and its 52-week low was $12.55. It is currently -25.14% from its 52-week high and 8.53% from its 52-week low.

How much is Crescent Capital Bdc stock worth today?

(NASDAQ: CCAP) Crescent Capital Bdc currently has 37,061,547 outstanding shares. With Crescent Capital Bdc stock trading at $13.62 per share, the total value of Crescent Capital Bdc stock (market capitalization) is $504.78M.

Crescent Capital Bdc stock was originally listed at a price of $16.40 in Feb 3, 2020. If you had invested in Crescent Capital Bdc stock at $16.40, your return over the last 3 years would have been -16.95%, for an annualized return of -6% (not including any dividends or dividend reinvestments).

How much is Crescent Capital Bdc's stock price per share?

(NASDAQ: CCAP) Crescent Capital Bdc stock price per share is $13.62 today (as of May 26, 2023).

What is Crescent Capital Bdc's Market Cap?

(NASDAQ: CCAP) Crescent Capital Bdc's market cap is $504.78M, as of May 28, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Crescent Capital Bdc's market cap is calculated by multiplying CCAP's current stock price of $13.62 by CCAP's total outstanding shares of 37,061,547.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.